ClinicalTrials.gg
RecruitingNCT06745232Updated Mar 7, 2025

New Stereophotogrammetry System to Capture Complete-arch Impression

An observational study in Prosthetic Complication and Prosthesis Failure, Dental, sponsored by University of Rome Tor Vergata. Recruiting at 1 site in Italy. Per ClinicalTrials.gov, last updated 2025-03-07.

Sponsored by University of Rome Tor Vergata · Observational

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Sex
All
01

Study summary

Patients in need of complete arch restorations will be treated with dynamic navigation system. Once the implants are positioned, a new system of stereophotogrammetry will record the implant positions to capture a precise impression to deliver a fixed screw retained interim prosthesis

02

Conditions studied

  • Prosthetic Complication
  • Prosthesis Failure, Dental

Browse trials for

Keywords

  • fixed prosthesis
  • stereophotogrammetry
  • immediate loading
03

In context

Prosthesis Failure

119 studies on the registry are indexed under Prosthesis Failure; 35 are open to participants now.

This study's planned enrollment of 10 is below the median of 119 across 49 observational studies indexed under Prosthesis Failure.

Browse Prosthesis Failure studies →

Lead sponsor

University of Rome Tor Vergata is the lead sponsor of 96 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients in need of complete arch rehabilitations with dental implants and fixed dental prosthesis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy patients aged ≥18 years
  2. Full mouth bleeding and full mouth plaque index lower than or equal to 25%
  3. Bone height for at least 10 mm long implants
  4. Bone width of at least 5 mm and 6 mm for narrow (NP 3.75/3.5 mm) and regular (RP 4.3 mm) implants, respectively
  5. Fresh extraction sockets with an intact buccal wall
  6. At least 4 and 5 mm of bone beyond the root apex in the mandible and maxilla
  7. Minimal insertion torque of 45 Ncm

Exclusion criteria

Exclusion Criteria:

  1. General medical (, ASA, class III or IV) and/or psychiatric
  2. Pregnancy and/or breastfeeding
  3. Any interfering medication such as therapy or bisphosphonate therapy
  4. Alcohol and/or drug abuse
  5. Heavy smoking (>10 cigarettes/day)
  6. Radiation therapy to head or neck region within 5 years
  7. Untreated periodontitis
  8. Acute and chronic infections of the adjacent tissues or natural dentition
  9. Severe maxillomandibular skeletal discrepancy
  10. High and moderate parafunctional activity
  11. Absence of opposite teeth
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • FAST MAP

    Patients with complete arch restorations loaded immediately with a full digital workflow using stereophotogrammetry Intraoral impression

    Device: FAST MAP

Interventions

  • DeviceFAST MAP

    Patients with complete arch restorations loaded immediately with a full digital workflow using stereophotogrammetry Intraoral impression

06

What researchers measure

Primary outcomes

  1. Prosthetic Success

    Prosthetic success of interim prosthesis in term of passivity and tissues adaptability

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06745232
Lead sponsor
University of Rome Tor Vergata
Responsible party
Paolo Carosi (Post-doc Researcher, University of Rome Tor Vergata) — Principal investigator
First posted
Dec 20, 2024
Start date
Jan 10, 2025
Primary completion
May 25, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
Mar 7, 2025

Study contacts

Paolo Carosi, PhD
Contact
paolo.carosi@alumni.uniroma2.eu
327798699 ext. +39

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion